Welcome to our dedicated page for Bunge Global SA SEC filings (Ticker: BG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bunge Global SA (NYSE: BG) SEC filings page brings together the company’s regulatory disclosures, giving investors and analysts direct access to the documents that explain its agribusiness and food operations in detail. As a Swiss-incorporated issuer with registered shares listed on the New York Stock Exchange, Bunge files annual, quarterly and current reports with the U.S. Securities and Exchange Commission under Commission File Number 000-56607.
Through Forms 10-K and 10-Q, Bunge provides information on its segments, including Agribusiness, Refined and Specialty Oils, Milling and Corporate and Other, and, more recently, its value-chain-based segments: Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. These reports describe how Bunge’s grain origination, oilseed processing and refining, and milling activities contribute to its results, and present both GAAP and non-GAAP metrics such as Segment EBIT and Adjusted Total EBIT.
Current reports on Form 8-K offer timely updates on material events, including earnings releases, changes in segment reporting, capital markets transactions, amendments to revolving credit agreements, expansions of commercial paper and securitization programs, and share capital changes following repurchases. Filings also document governance matters, such as executive transitions and amendments to the Articles of Association.
On Stock Titan, these filings are supplemented with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand changes in Bunge’s capital structure, liquidity facilities, segment performance and risk disclosures. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K and related exhibits appear promptly, while insider transaction reports on Form 4, when filed, can be used to monitor trading by directors and officers. This combination of primary documents and AI explanations allows users to navigate Bunge’s complex agribusiness value chains through its official SEC record.
Bunge Global SA reported that one of its directors acquired additional equity on December 1, 2025. The director received 18 restricted stock units of Bunge Global SA common stock as a result of a dividend feature under the company’s long-term incentive plans, rather than through an open-market purchase.
The transaction is coded as an acquisition at a reference price of $96.47 per share. Following this award, the reporting person beneficially owns a total of 33,441.7968 shares of Bunge Global SA common stock in direct ownership form.
Bunge Global SA reported a small insider equity award for one of its directors. On December 1, 2025, the director acquired 15 shares of common stock at a price of $96.47 per share. The filing explains that these shares represent restricted stock units granted on that date under a dividend feature in Bunge Global’s long-term incentive plans, meaning the award reflects dividends credited in stock rather than cash. After this transaction, the director beneficially owns 2,197 shares of Bunge Global common stock directly.
Bunge Global SA director reported a small equity award under the company’s long-term incentive plans. On December 1, 2025, the reporting person acquired 18 shares of common stock at a price of $96.47 per share through restricted stock units credited via a dividend feature. After this transaction, the director beneficially owned 8,783 shares directly. This filing reflects routine equity-based compensation rather than an open-market purchase or sale.
Bunge Global SA director reported a small equity award related to their existing holdings. On 12/01/2025, the insider acquired 15 shares of common stock at $96.47 per share through restricted stock units credited under a dividend feature in the company's long-term incentive plans. Following this routine transaction, the reporting person beneficially owned 7,197 shares directly. This reflects ongoing participation in Bunge's equity-based compensation and dividend programs rather than an open-market purchase or sale.
Bunge Global SA director reports a small equity award. A company director acquired 34 shares of Bunge Global SA common stock on December 1, 2025 as restricted stock units with a value reference of $96.47 per share, granted under the company’s long-term incentive plans through a dividend feature. After this transaction, the director beneficially owns 21,871 shares directly and 6,500 shares indirectly through the Zenuk Family Living Trust u/a/d 09/01/2015.
Bunge Global SA (BG) reported an insider transaction by its Executive VP, Global Markets. On 11/21/2025, the officer exercised stock options to acquire 5,300 shares of common stock at an exercise price of $50.07 per share and then sold shares on the same day.
The reported sales included 5,300 shares of common stock at a weighted average price of $94.3823 per share (from trades between $94.30 and $94.48) and an additional 20,000 shares at a weighted average price of $94.3709 per share (from trades between $94.28 and $94.44). After these transactions, the officer beneficially owned 104,536.808 shares of Bunge Global SA common stock directly.
The derivative position reported was a stock option (right to buy) for 5,300 shares at $50.07, which was exercised on 11/21/2025, leaving 0 such derivative securities owned. The option had become exercisable in three equal annual installments beginning on March 1, 2017.
BG filed a Form 144 notice for a proposed sale of common stock. The filing covers 25,300 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, with an aggregate market value of $2,387,641.66. The filing reports that there were 193,361,047 shares of this class outstanding and lists an approximate sale date of 11/21/2025. The seller acquired 5,300 shares via a stock option exercise dated 11/21/2025 and 20,000 shares as performance shares dated 03/15/2024.
Capital World Investors, a division of Capital Research and Management Company and its affiliates, has filed an amended Schedule 13G reporting its beneficial ownership in Bunge Global SA (BG) common stock. The firm is deemed to beneficially own 16,612,661 shares, representing 8.3% of the 200,062,018 shares believed to be outstanding as of the event date. It reports sole voting power over 16,474,937 shares and sole dispositive power over 16,612,661 shares, with no shared voting or dispositive power.
The filer states that the securities were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of Bunge Global SA, consistent with a passive institutional investment position.
State Street Corporation filed a Schedule 13G reporting passive ownership in Bunge Global SA (BG). As of 09/30/2025, State Street beneficially owned 6,921,849 shares of common stock, representing 3.5% of the class.
The filing shows 0 shares with sole voting or dispositive power, 4,499,949 shares with shared voting power, and 6,921,322 shares with shared dispositive power. State Street certified the securities were acquired and are held in the ordinary course of business and not to change or influence control. The reporting person is classified as HC (parent holding company), with multiple investment adviser subsidiaries listed.
Bunge Global SA (BG) filed its Q3 2025 report, reflecting the first quarter with Viterra consolidated. Net sales were $22,155 million versus $12,908 million a year ago, while net income attributable to Bunge shareholders was $166 million versus $221 million. Diluted EPS was $0.84 versus $1.56. Gross profit increased to $1,063 million and SG&A rose to $678 million, with higher interest expense at $202 million.
Bunge closed the Viterra acquisition on July 2, 2025 for total purchase consideration of $10,617 million, including about 65.6 million Bunge registered shares valued at $5,340 million and $1,880 million in cash; sellers now own approximately 33% of Bunge’s registered shares. Total assets rose to $46,298 million from $24,899 million at year-end, and long-term debt increased to $9,809 million with short-term debt at $4,446 million. The company completed the EU Oilseeds Divestment for cash proceeds of $483 million and sold its North America corn milling business for $470 million, recognizing a $155 million gain. Cash used in operating activities for the nine months was $503 million. Registered shares outstanding were 193,361,047 as of November 3, 2025.